We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

98% less funds holding

Funds holding: 546 → 12 (-534)

98% less capital invested

Capital invested by funds: $338M → $5.25M (-$333M)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 529

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
Jet Capital Investors
New York
+$2.15M
2
TNB
Thomasville National Bank
Georgia
+$146K

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$47.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.6M
3
ACM
Abrams Capital Management
Massachusetts
-$17.1M
4
FCM
Farallon Capital Management
California
-$14.8M
5
BFS
Bard Financial Services
Connecticut
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSV Asset Management
126
LSV Asset Management
Illinois
– -$139K -202,837 Closed
Royal Bank of Canada
127
Royal Bank of Canada
Ontario, Canada
– -$139K -202,142 Closed
FAF
128
Fjarde Ap-fonden
Sweden
– -$138K -200,416 Closed
KC
129
Kepos Capital
New York
– -$138K -200,000 Closed
CS
130
Candriam SCA
Luxembourg
– -$134K -194,693 Closed
Norges Bank
131
Norges Bank
Norway
– -$133K -192,682 Closed
DekaBank Deutsche Girozentrale
132
DekaBank Deutsche Girozentrale
Germany
– -$301K -188,420 Closed
ZIC
133
ZWJ Investment Counsel
Georgia
– -$126K -181,864 Closed
HS
134
HighVista Strategies
Massachusetts
– -$124K -180,400 Closed
Ameriprise
135
Ameriprise
Minnesota
– -$124K -180,174 Closed
Canada Life
136
Canada Life
Manitoba, Canada
– -$123K -177,067 Closed
RJA
137
Raymond James & Associates
Florida
– -$110K -159,511 Closed
GT
138
Glenmede Trust
Pennsylvania
– -$107K -157,911 Closed
VRS
139
Virginia Retirement Systems
Virginia
– -$108K -157,100 Closed
AGM
140
Alpine Global Management
New York
– -$102K -150,000 Closed
PAG
141
Private Advisor Group
New Jersey
– -$101K -147,024 Closed
VI
142
Vestcor Inc
New Brunswick, Canada
– -$95K -137,500 Closed
OAC
143
OMERS Administration Corp
Ontario, Canada
– -$94K -136,300 Closed
HM
144
Harvest Management
New York
– -$91K -132,000 Closed
LA
145
LVW Advisors
New York
– -$91K -131,200 Closed
CB
146
Commerce Bank
Missouri
– -$90K -129,832 Closed
FDCDDQ
147
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$88.3K -127,925 Closed
Verition Fund Management
148
Verition Fund Management
Connecticut
– -$86K -124,872 Closed
BPGAM
149
BTG Pactual Global Asset Management
Bermuda
– -$86K -124,789 Closed
Commonwealth Equity Services
150
Commonwealth Equity Services
Massachusetts
– -$85K -123,227 Closed
4 5
6
7 8

BMY.RT Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q1 2021, worth a combined $5.25M — down 98% from $338M a quarter earlier.

Sellers outnumbered buyers: 529 funds closed out of BMY.RT and 2 opened new positions — a net loss of 527 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jet Capital Investors, adding an estimated $2.15M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $47.7M sold.

  • 12 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q1 2021, down from 546 in Q4 2020.
  • Funds reported $5.25M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q1 2021, down 98% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q1 2021 and 529 closed out, a net change of -527 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q1 2021 was Jet Capital Investors, an estimated $2.15M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q1 2021 was Pentwater Capital Management, an estimated $47.7M sold.

Based on aggregated 13F filings for Q1 2021.